Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome

Ponatinib (AP24534), a Multitargeted Pan-FGFR Inhibitor with Activity in Multiple FGFR-Amplified or Mutated Cancer Models

(2012) J. M. Gozgit et al.   MOLECULAR CANCER THERAPEUTICS

A novel t(1;8)(q25;p11.2) translocation associated with 8p11 myeloproliferative syndrome

(2011) Chikamasa Yoshida et al.   BRITISH JOURNAL OF HAEMATOLOGY

The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)

(2011) B. Wasag et al.   HAEMATOLOGICA

8p11 myeloproliferative syndrome: a review

(2010) Courtney C. Jackson et al.   HUMAN PATHOLOGY

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr

(2009) Iris Ben-Efraim et al.   BMC CELL BIOLOGY